Patent details

92615 Product Name: alogliptin et ses dérivés pharmaceutiquemetn acceptables (VIPIDIA)

Basic Information

Publication number:
92615
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP001194968
Legal Status:
Lapsed
Application number:
92615
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
23/04/2020
SPC Extension Agent Name:
OFFICE FREYLINGER S.A.
SPC Extension Status:
Invalid
SPC Extension Grant Date:
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/13/844 - Vipidia - alogliptin
Marketing Authorization Type:
Marketing Authorization Date:
23/09/2013
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
15/12/2014
First Marketing Authorization date:
23/09/2013
Grant date:
21/10/2015
Activation date:
24/04/2017
Publication date:
21/10/2015
Lapsed date:
24/04/2021
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
24/04/2022
SPC Extension Expiration:
24/10/2022
Rejection date:
Withdrawal date:

Owner

From:
15/12/2014
 
 

Name:
Royalty Pharma Collection Trust
Address:
Rodney Square North 1100 North Market Street, Wilmington DE 19890, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
15/12/2014
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
McIntosh Christopher H.S.
Address:
Canada (CA)

2

Name:
Schmidt Jörn
Address:
Germany (DE)

3

Name:
Demuth Hans-Ulrich
Address:
Germany (DE)

4

Name:
Rosche Fred
Address:
Germany (DE)

5

Name:
Pauly Robert P., Dr., Walter McKenzie Centre
Address:
Canada (CA)

6

Name:
Pederson Ray A.
Address:
Canada (CA)

Publication

Bulletin

1

Bulletin Heading:
SPC3
Bulletin edition number:
2017/02
Publication date:
22/06/2017
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2020/06
Publication date:
07/05/2020
Description:
Section G : Applications for extensions for pediatric use – I1E publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
30/04/2020
Last Annual Fee Paid Number:
24
Last Annual Fee Paid Amount:
440 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Number of pages
23/04/2020 General Document 3
23/04/2020 General Document 10
23/04/2020 FNET_DC_FRONTPAGE 1
23/04/2020 Outgoing Correspondence 1
23/04/2020 Publication 1
23/04/2020 General Document 66
23/04/2020 General Document 2
23/04/2020 Application Form 4